783: COMPARATIVE COHORT STUDY OF REVERSAL AGENTS FOR BLEEDING ASSOCIATED WITH FACTOR XA INHIBITORS

Authors

Matthew D. Painter MD, Lehigh Valley Health NetworkFollow
Jason Laskosky PharmD, BCPS, Lehigh Valley Health NetworkFollow
Alhussain Yasin
Joseph Ottinger RPh, MS, MBA, BCPS, Lehigh Valley Health NetworkFollow
Kyle Shaak BS, Lehigh Valley Health NetworkFollow
Mark Cipolle MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

1-2023

Volume

51

Issue

1

First Page

382

Last Page

382

Published In/Presented At

Painter, Matthew1; Laskosky, Jason1; Yasin, Alhussain2; Ottinger, Joseph1; Shaak, Kyle3; Cipolle, Mark4. 783: COMPARATIVE COHORT STUDY OF REVERSAL AGENTS FOR BLEEDING ASSOCIATED WITH FACTOR XA INHIBITORS. Critical Care Medicine 51(1):p 382, January 2023. | DOI: 10.1097/01.ccm.0000908864.61803.12

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery, Department of Pharmacy, Network Office of Research and Innovation

Document Type

Article